BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 28535204)

  • 21. Structural Insights into
    Detzner J; Gloerfeld C; Pohlentz G; Legros N; Humpf HU; Mellmann A; Karch H; Müthing J
    Microorganisms; 2019 Nov; 7(11):. PubMed ID: 31752441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of PS 18:0/18:1 in membrane function.
    Skotland T; Sandvig K
    Nat Commun; 2019 Jun; 10(1):2752. PubMed ID: 31227693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble Toll-Like Receptor 4 Impairs the Interaction of Shiga Toxin 2a with Human Serum Amyloid P Component.
    Brigotti M; Arfilli V; Carnicelli D; Ricci F; Tazzari PL; Ardissino G; Scavia G; Morabito S; He X
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30231570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane assembly of Shiga toxin glycosphingolipid receptors and toxin refractiveness of MDCK II epithelial cells.
    Legros N; Pohlentz G; Steil D; Kouzel IU; Liashkovich I; Mellmann A; Karch H; Müthing J
    J Lipid Res; 2018 Aug; 59(8):1383-1401. PubMed ID: 29866658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shiga Toxin Glycosphingolipid Receptors in Human Caco-2 and HCT-8 Colon Epithelial Cell Lines.
    Kouzel IU; Pohlentz G; Schmitz JS; Steil D; Humpf HU; Karch H; Müthing J
    Toxins (Basel); 2017 Oct; 9(11):. PubMed ID: 29068380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shiga toxin glycosphingolipid receptors and their lipid membrane ensemble in primary human blood-brain barrier endothelial cells.
    Legros N; Dusny S; Humpf HU; Pohlentz G; Karch H; Müthing J
    Glycobiology; 2017 Jan; 27(1):99-109. PubMed ID: 27558838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Human Renal Proximal Tubular Epithelial Cells (pHRPTEpiCs): Shiga Toxin (Stx) Glycosphingolipid Receptors, Stx Susceptibility, and Interaction with Membrane Microdomains.
    Detzner J; Klein AL; Pohlentz G; Krojnewski E; Humpf HU; Mellmann A; Karch H; Müthing J
    Toxins (Basel); 2021 Jul; 13(8):. PubMed ID: 34437399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity.
    Detzner J; Krojnewski E; Pohlentz G; Steil D; Humpf HU; Mellmann A; Karch H; Müthing J
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33673393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.
    Steil D; Schepers CL; Pohlentz G; Legros N; Runde J; Humpf HU; Karch H; Müthing J
    J Lipid Res; 2015 Dec; 56(12):2322-36. PubMed ID: 26464281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary Human Colon Epithelial Cells (pHCoEpiCs) Do Express the Shiga Toxin (Stx) Receptor Glycosphingolipids Gb3Cer and Gb4Cer and Are Largely Refractory but Not Resistant towards Stx.
    Detzner J; Püttmann C; Pohlentz G; Humpf HU; Mellmann A; Karch H; Müthing J
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colocalization of receptors for Shiga toxins with lipid rafts in primary human renal glomerular endothelial cells and influence of D-PDMP on synthesis and distribution of glycosphingolipid receptors.
    Legros N; Pohlentz G; Runde J; Dusny S; Humpf HU; Karch H; Müthing J
    Glycobiology; 2017 Oct; 27(10):947-965. PubMed ID: 28535204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shiga toxin-glycosphingolipid interaction: Status quo of research with focus on primary human brain and kidney endothelial cells.
    Legros N; Pohlentz G; Steil D; Müthing J
    Int J Med Microbiol; 2018 Dec; 308(8):1073-1084. PubMed ID: 30224239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enterohemorrhagic
    Detzner J; Pohlentz G; Müthing J
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805890
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.